The DGKH Polyclonal Antibody (PACO08815) is a valuable tool for researchers studying Diacylglycerol kinase eta (DGKH) and its role in various cellular processes. This antibody, raised in rabbits, specifically targets DGKH protein and is highly reactive with human samples. Validated for use in Western blot applications, it allows for the detection and analysis of DGKH in different cell types, making it ideal for studies in cell signaling, lipid metabolism, and neurological disorders.DGKH is a key enzyme involved in the metabolism of diacylglycerol, a lipid molecule with crucial functions in cell signaling pathways.
Dysregulation of DGKH has been linked to neurological disorders such as bipolar disorder and schizophrenia, making it a promising therapeutic target for drug development. By understanding the role of DGKH in cellular processes, researchers can gain insights into the pathophysiology of these disorders and potentially identify new treatment strategies.
